Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Bankruptcy

- PMLiVE

Purdue to pay over $8bn to settle opioid-related criminal claims

Claims relate to Purdue's involvement in fuelling the opioid addiction crisis

- PMLiVE

Mallinckrodt files for bankruptcy protection in the US

Bankruptcy filing will reduce debts related to legal liabilities

- PMLiVE

US piles pressure on Mallinckrodt over alleged Acthar fraud

Drugmaker allegedly underpaid rebates owed to Medicaid

- PMLiVE

Mallinckrodt reaches tentative $1.6bn opioid settlement

Agreement reached with a plaintiff's executive committee

- PMLiVE

FDA committee rejects Intellipharmaceutics’ opioid drug Aximris

Verdict closely follows rejection of Nektar’s opioid analgesic

- PMLiVE

Nektar’s opioid analgesic slammed with FDA panel rejection

Panelists unanimously rejected use of the chronic back pain drug

- PMLiVE

Antibiotic biotech Melinta files for bankruptcy

Worries over antibiotic business model continue to mount

- PMLiVE

J&J appeals Oklahoma opioid verdict, claiming ‘errors’ in trial

Cites misuse of public nuisance laws as grounds for appeal

- PMLiVE

Teva names new CFO and bulks up its opioid liability fund

Opioid liability issue overshadowed the company's Q3 results

- PMLiVE

UPDATED: Ohio opioid trial averted by last-minute settlement

Drug manufacturers reach settlement hours before trial set to begin

- PMLiVE

J&J proposes $4bn in cash to settle opioid crisis allegations

Upcoming federal trial puts a number of companies in the spotlight

- PMLiVE

Insys gets bankruptcy court okay for Subsys sale

Opioid product was focus of racketeering charges

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links